NewsBenzingaTruist Securities Maintains Hold on KB Home, Lowers Price Target to $50 Truist Securities Maintains Hold on KB Home, Lowers Price Target to $50 Benzinga 2026.09.23 16:14 (GMT+0) Open on Benzinga Other news Swedish Government Offices to Ban ChatGPT and Claude, Keeping Only Microsoft Copilot Amgen Inc. (AMGN) Presents at 2026 European Society for Medical Oncology (ESMO) Annual Congress Transcript Navient Corporation (NAVI) Discusses Corporate Reorganization and Strategic Realignment of Business Structure - Slideshow (NASDAQ:NAVI) 2026-10-24 Vinci Compass Investments Ltd. (VINP) Vinci Compass Investments Ltd. - M&A Call - Slideshow (NASDAQ:VINP) 2026-10-24 Roivant Sciences Ltd. (ROIV) Discusses Phase 3 Results for Brepocitinib in Non-Infectious Uveitis - Slideshow (NASDAQ:ROIV) 2026-10-24 Lexeo Therapeutics, Inc. (LXEO) Discusses Clinical Assessment and Unmet Need in PKP2 Arrhythmogenic Cardiomyopathy - Slideshow (NASDAQ:LXEO) 2026-10-24
Amgen Inc. (AMGN) Presents at 2026 European Society for Medical Oncology (ESMO) Annual Congress Transcript
Navient Corporation (NAVI) Discusses Corporate Reorganization and Strategic Realignment of Business Structure - Slideshow (NASDAQ:NAVI) 2026-10-24
Vinci Compass Investments Ltd. (VINP) Vinci Compass Investments Ltd. - M&A Call - Slideshow (NASDAQ:VINP) 2026-10-24
Roivant Sciences Ltd. (ROIV) Discusses Phase 3 Results for Brepocitinib in Non-Infectious Uveitis - Slideshow (NASDAQ:ROIV) 2026-10-24
Lexeo Therapeutics, Inc. (LXEO) Discusses Clinical Assessment and Unmet Need in PKP2 Arrhythmogenic Cardiomyopathy - Slideshow (NASDAQ:LXEO) 2026-10-24
